AIPT - Precision Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue654.836456.495654.354951.559
Cost of Revenue148.045181.62303.982385.323
Gross Profit506.791274.875350.372566.236
Operating Expenses
Research Development----
Selling General and Administrative8,253.3845,781.8864,750.0157,033.684
Non Recurring----
Others----
Total Operating Expenses8,401.4295,963.5065,053.9977,419.007
Operating Income or Loss-7,746.593-5,507.011-4,399.643-6,467.448
Income from Continuing Operations
Total Other Income/Expenses Net--1,019.003-390.887-366.12
Earnings Before Interest and Taxes-7,746.593-5,507.011-4,399.643-6,467.448
Interest Expense--0.003-390.887-377.719
Income Before Tax-7,746.593-6,526.014-4,790.53-6,833.568
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-7,746.593-6,526.014-4,790.53-6,833.568
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-7,746.593-6,526.014-4,790.53-6,833.568
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-7,746.593-6,526.014-4,790.53-6,833.568